Inhibition of hedgehog signalling attenuates <scp>UVB</scp>‐induced skin photoageing
-
- Wanyeon Kim
- Department of Biological Sciences Pusan National University Busan South Korea
-
- EunGi Kim
- Department of Integrated Biological Science Pusan National University Busan South Korea
-
- Hee Jung Yang
- Department of Biological Sciences Pusan National University Busan South Korea
-
- TaeWoo Kwon
- Department of Integrated Biological Science Pusan National University Busan South Korea
-
- SeoYoung Han
- Department of Integrated Biological Science Pusan National University Busan South Korea
-
- Sungmin Lee
- Department of Integrated Biological Science Pusan National University Busan South Korea
-
- HyeSook Youn
- Department of Biological Sciences Pusan National University Busan South Korea
-
- Youngmi Jung
- Department of Biological Sciences Pusan National University Busan South Korea
-
- ChulHee Kang
- Department of Chemistry Washington State University Pullman Washington USA
-
- BuHyun Youn
- Department of Biological Sciences Pusan National University Busan South Korea
書誌事項
- 公開日
- 2015-05-26
- 権利情報
-
- http://onlinelibrary.wiley.com/termsAndConditions#vor
- DOI
-
- 10.1111/exd.12735
- 公開者
- Wiley
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>The hedgehog (Hh) signalling pathway regulates normal development and cell proliferation in metazoan organisms, but its aberrant activation can promote tumorigenesis and progression of a variety of aggressive human cancers including skin cancer. Despite its importance, little is known about its role in photoageing, a type of <jats:styled-content style="fixed-case">UV</jats:styled-content>‐induced skin lesions. In this study, we investigated the involvement of Hh signalling in the photoageing process as well as the use of an Hh‐regulating alkaloid compound as a novel therapeutic drug to regulate photoageing in keratinocytes. We found that <jats:styled-content style="fixed-case">UVB</jats:styled-content> induced Hh signalling by the expression of Hh ligands and Hh‐mediated transcription factors, respectively. Moreover, <jats:styled-content style="fixed-case">UVB</jats:styled-content>‐induced Hh activation relied on mitogen‐activated protein kinase (p38, <jats:styled-content style="fixed-case">ERK</jats:styled-content> and <jats:styled-content style="fixed-case">JNK</jats:styled-content>) activity and inflammatory responses (upregulation of <jats:styled-content style="fixed-case">COX</jats:styled-content>‐2, <jats:styled-content style="fixed-case">IL</jats:styled-content>‐1<jats:italic>β</jats:italic>,<jats:styled-content style="fixed-case"> IL</jats:styled-content>‐6 and <jats:styled-content style="fixed-case">TNF</jats:styled-content>‐<jats:italic>α</jats:italic>), resulting in premature senescence and photoageing <jats:italic>in vitro</jats:italic> and <jats:italic>in vivo</jats:italic>. Notably, a selected Hh inhibitor, evodiamine, mediated photoageing blockade in a mouse skin model. Taken together, our findings demonstrated that Hh signalling is associated with <jats:styled-content style="fixed-case">UVB</jats:styled-content>‐induced photoageing, while pharmacological inhibition of Hh signalling significantly reduced experimental photoageing, indicating its potential for use as a therapeutic target for this disease.</jats:p>
収録刊行物
-
- Experimental Dermatology
-
Experimental Dermatology 24 (8), 611-617, 2015-05-26
Wiley